Delivery Order SPE2DB20D1100-SPE2DB23FD2S9
Award Date 8/25/23
Potential Completion Date 8/28/23
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $17,719 delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML syringes. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania to support DLA requirements. STELARA is a biologic medication used to treat autoimmune diseases such as plaque psoriasis and Crohn's disease. As a leading provider of pharmaceuticals and medical supplies, Amerisourcebergen will deliver the syringes under its...
- The Defense Logistics Agency awarded a $20,239 delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML syringes. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania through August 7, 2023 to support DLA programs. No subcontractors or set aside designations were specified. The award draws from DLA's indefinite-delivery/indefinite-quantity pharmaceutical prime vendor contract vehicle to provide rheumatoid arthritis medication...
- The Defense Logistics Agency awarded a $7,299.38 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561771997 STELARA 45 MG/0.5 ML SYRINGE 0.5ML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 10-11, 2023. As the DLA supports military medical readiness by procuring pharmaceuticals and other medical commodities, this order for STELARA injections, used to treat autoimmune diseases such...
- The Defense Logistics Agency Troop Support Medical awarded a $10,987.91 firm fixed price delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML syringes. The delivery order, issued under an unspecified governmentwide acquisition contract, calls for Amerisourcebergen to provide the specified pharmaceutical to the agency. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three day period concluding on June 26, 2023. No subcontractors...
- The Defense Logistics Agency awarded a $29,171.56 firm fixed price delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML syringes. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 28, 2023. No subcontractors or set aside designations were identified....
- The Defense Logistics Agency Troop Support Medical awarded a $44,802 firm fixed price delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML SYRINGEML. The place of performance is Conshohocken, Pennsylvania. The one day contract runs from June 22, 2023 through June 23, 2023. As a major supplier of pharmaceuticals to the Department of Defense, this order for the rheumatoid arthritis treatment STELARA supports the Defense Logistics Agency's mission to provide medical supplies...
- The Defense Logistics Agency awarded a $24,095.52 firm fixed price delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML syringes. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DOD and other federal agencies. Performance will take place in Conshohocken, Pennsylvania from August 16-17, 2023. No subcontractors or set aside designations were identified. The award supports DLA's...
- The Defense Logistics Agency awarded a $4,082 delivery order to Amerisourcebergen Drug Corporation for STELARA 45 MG/0.5 ML syringes. The firm fixed price order is for delivery to a location in Conshohocken, Pennsylvania by August 28, 2023, with performance beginning on August 25. As a major provider of medical supplies and pharmaceuticals to the U.S. Department of Defense, this order for the rheumatoid arthritis treatment STELARA supports the Defense Logistics Agency's mission to provide...
- The Defense Logistics Agency Troop Support Medical awarded a $54,135.76 firm fixed price delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML SYRINGEML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 5, 2023 through July 6, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order for STELARA, an immunosuppressive drug used to treat various...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order valued at $182,528.85 to Amerisourcebergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide STELARA 90 MG/ML SYRINGEML. This order was placed under an existing DLA contract for the supply of pharmaceuticals and medical supplies to support military treatment programs and facilities. The order is scheduled for completion by February 15, 2023. No set-aside designation was used for this award, which will...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB23FD2S9Delivery Order
The Defense Logistics Agency awarded a $13,547 delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML syringes. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania through August 28, 2023 to support DLA programs. No subcontractors or set aside designations were identified. STELARA is a biologic medication used to treat autoimmune diseases such as plaque psoriasis and inflammatory bowel disease. This award draws upon DLA's Federal Supply Schedule for pharmaceuticals to ensure military treatment facilities have access to necessary medicines.
Generated 12/24/23, 5:08 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.5k | 8/25/23 |